David A. Siegel Phibro Animal Health Corp Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Phibro Animal Health Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 26,100 shares of PAHC stock, worth $638,406. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,100

Previous 64,100 59.28%

Holding current value

$638,406

Previous $1.07 Million 45.34%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.39 - $22.5 $622,820 - $855,000	-38,000 Reduced 59.28%	26,100 $587,000
Q2 2024 Aug 14, 2024	SELL	$12.44 - $18.55 $465,256 - $693,770	-37,400 Reduced 36.85%	64,100 $1.07 Million
Q1 2024 May 15, 2024	BUY	$10.63 - $13.68 $53,150 - $68,400	5,000 Added 5.18%	101,500 $1.31 Million
Q4 2023 Feb 14, 2024	BUY	$9.59 - $12.91 $355,789 - $478,961	37,100 Added 62.46%	96,500 $1.12 Million
Q3 2023 Nov 14, 2023	BUY	$12.43 - $15.29 $88,253 - $108,559	7,100 Added 13.58%	59,400 $758,000
Q2 2023 Aug 14, 2023	SELL	$12.92 - $15.89 $83,980 - $103,285	-6,500 Reduced 11.05%	52,300 $716,000
Q1 2023 May 15, 2023	SELL	$13.67 - $16.37 $255,629 - $306,119	-18,700 Reduced 24.13%	58,800 $900,000
Q4 2022 Feb 14, 2023	BUY	$12.05 - $15.14 $68,685 - $86,298	5,700 Added 7.94%	77,500 $1.04 Million
Q3 2022 Nov 14, 2022	BUY	$12.82 - $20.22 $328,192 - $517,632	25,600 Added 55.41%	71,800 $954,000
Q2 2022 Aug 15, 2022	SELL	$17.89 - $20.47 $436,516 - $499,468	-24,400 Reduced 34.56%	46,200 $884,000
Q1 2022 May 16, 2022	BUY	$18.39 - $21.85 $11,034 - $13,110	600 Added 0.86%	70,600 $1.41 Million
Q4 2021 Feb 14, 2022	BUY	$18.96 - $22.76 $178,224 - $213,944	9,400 Added 15.51%	70,000 $1.43 Million
Q3 2021 Nov 15, 2021	BUY	$20.59 - $30.01 $899,783 - $1.31 Million	43,700 Added 258.58%	60,600 $1.31 Million
Q2 2021 Aug 16, 2021	SELL	$24.15 - $30.08 $154,560 - $192,512	-6,400 Reduced 27.47%	16,900 $488,000
Q1 2021 May 17, 2021	SELL	$19.71 - $25.23 $100,521 - $128,673	-5,100 Reduced 17.96%	23,300 $569,000
Q4 2020 Feb 16, 2021	SELL	$16.44 - $20.2 $141,384 - $173,720	-8,600 Reduced 23.24%	28,400 $552,000
Q3 2020 Nov 16, 2020	SELL	$17.36 - $26.36 $588,504 - $893,604	-33,900 Reduced 47.81%	37,000 $644,000
Q2 2020 Aug 14, 2020	SELL	$22.31 - $28.29 $133,860 - $169,740	-6,000 Reduced 7.8%	70,900 $1.86 Million
Q1 2020 May 15, 2020	SELL	$17.75 - $27.72 $24,850 - $38,808	-1,400 Reduced 1.79%	76,900 $1.86 Million
Q4 2019 Feb 14, 2020	BUY	$21.0 - $24.83 $222,600 - $263,198	10,600 Added 15.66%	78,300 $1.94 Million
Q3 2019 Nov 14, 2019	BUY	$20.34 - $32.66 $490,194 - $787,105	24,100 Added 55.28%	67,700 $1.44 Million
Q2 2019 Aug 14, 2019	SELL	$28.03 - $36.85 $594,236 - $781,220	-21,200 Reduced 32.72%	43,600 $1.39 Million
Q1 2019 May 15, 2019	BUY	$28.71 - $33.65 $1.02 Million - $1.2 Million	35,600 Added 121.92%	64,800 $2.14 Million
Q4 2018 Feb 14, 2019	SELL	$31.18 - $44.64 $15,590 - $22,320	-500 Reduced 1.68%	29,200 $939,000
Q3 2018 Nov 14, 2018	SELL	$42.3 - $53.5 $93,060 - $117,700	-2,200 Reduced 6.9%	29,700 $1.27 Million
Q2 2018 Aug 14, 2018	SELL	$38.7 - $48.1 $46,440 - $57,720	-1,200 Reduced 3.63%	31,900 $1.47 Million
Q1 2018 May 15, 2018	SELL	$32.2 - $40.45 $41,860 - $52,585	-1,300 Reduced 3.78%	33,100 $1.31 Million
Q4 2017 Feb 14, 2018	SELL	$32.65 - $37.9 $267,730 - $310,780	-8,200 Reduced 19.25%	34,400 $1.15 Million
Q3 2017 Nov 14, 2017	BUY	$35.0 - $40.0 $1.49 Million - $1.7 Million	42,600	42,600 $1.58 Million

Others Institutions Holding PAHC

# of Institutions

148

Shares Held

20.5M

Call Options Held

Put Options Held

View Full List

About PHIBRO ANIMAL HEALTH CORP

Ticker PAHC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,337,600
Market Cap $497M
Description
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...

More about PAHC

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account